| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 931.54B | 916.71B | 950.29B | 864.72B | 760.72B | 706.38B |
| Gross Profit | 106.93B | 96.67B | 106.67B | 95.83B | 96.05B | 97.24B |
| EBITDA | 101.58B | 108.89B | 104.04B | 91.32B | 97.76B | 97.97B |
| Net Income | 40.08B | 46.24B | 40.88B | 29.66B | 38.34B | 37.61B |
Balance Sheet | ||||||
| Total Assets | 906.57B | 889.95B | 965.60B | 905.91B | 855.24B | 782.16B |
| Cash, Cash Equivalents and Short-Term Investments | 270.30B | 276.15B | 302.87B | 315.04B | 323.94B | 303.89B |
| Total Debt | 7.60B | 10.38B | 18.77B | 27.46B | 25.22B | 21.19B |
| Total Liabilities | 217.35B | 210.08B | 246.32B | 235.40B | 227.92B | 212.72B |
| Stockholders Equity | 631.03B | 627.20B | 671.93B | 628.83B | 591.16B | 537.83B |
Cash Flow | ||||||
| Free Cash Flow | 42.62B | 39.16B | 59.05B | 19.93B | 36.77B | 41.43B |
| Operating Cash Flow | 96.90B | 88.36B | 96.37B | 59.76B | 65.71B | 74.96B |
| Investing Cash Flow | 32.09B | -40.99B | -50.16B | -71.54B | -52.15B | -1.09B |
| Financing Cash Flow | -70.05B | -78.35B | -59.68B | -13.28B | -8.49B | -18.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥45.62B | 7.97 | 8.46% | 2.64% | -6.35% | 18.49% | |
78 Outperform | ¥276.86B | 8.56 | 6.37% | 2.88% | 4.86% | 10.95% | |
76 Outperform | ¥706.34B | 14.05 | 7.20% | 2.41% | -0.73% | 88.36% | |
75 Outperform | ¥473.04B | 7.76 | 8.58% | 2.62% | 1.44% | -0.92% | |
74 Outperform | ¥144.08B | 10.91 | ― | 2.93% | 1.77% | 117.03% | |
67 Neutral | ¥5.25T | 10.20 | 6.98% | 2.98% | 2.41% | 11.03% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |